Moreover, although it is known that aging and menopause are associated with an increased risk of insulin resistance and the development of T2D (38, 39), it is still not known whether an increase in OCT3 mRNA levels, and thus a decrease in stimulated lipolysis, could function as a compensatory mechanism to limit insulin resistance. Here, SLC22A3 is linked to Insulin resistance.